NCT00923442
Biology Studies of Hematologic Cancers
Enrolling by Invitation
Not specifiedAges 1+ObservationalNational Cancer Institute (NCI)Government-funded
~550 participants
Updated 2026-07-16 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Tissue acquisition for lab investigations
Measured over 1 Month
Conditions
NCT00923442
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
National Institutes of Health Clinical Center
Bethesda, Marylandno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- John W Glod, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Tissue acquisition for lab investigations1 Month
The examination of biologic assays relevant to the investigation of hematologic malignancies